New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular Carcinoma
2013; Radiological Society of North America; Volume: 266; Issue: 2 Linguagem: Inglês
10.1148/radiol.12121698
ISSN1527-1315
AutoresChristoph Wald, Mark W. Russo, Julie K. Heimbach, Hero K. Hussain, Elizabeth A. Pomfret, Jordi Bruix,
Tópico(s)Organ Transplantation Techniques and Outcomes
ResumoHomeRadiologyVol. 266, No. 2 PreviousNext Reviews and CommentaryEditorialsNew OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular CarcinomaChristoph Wald , Mark W. Russo, Julie K. Heimbach, Hero K. Hussain, Elizabeth A. Pomfret, Jordi BruixChristoph Wald , Mark W. Russo, Julie K. Heimbach, Hero K. Hussain, Elizabeth A. Pomfret, Jordi BruixAuthor AffiliationsFrom the Departments of Radiology (C.W.) and Transplantation and Hepatobiliary Diseases (E.A.P.), Lahey Clinic Medical Center, Tufts University Medical School, 41 Mall Rd, Burlington, MA 01805; Division of Hepatology, Carolinas Medical Center, Charlotte, NC (M.W.R.); Department of Surgery, Mayo Clinic, Rochester, Minn (J.K.H.); Department of Radiology, University of Michigan Hospital, Ann Arbor, Mich (H.K.H.); and Barcelona Clinic Liver Cancer Group, Hospital Clínic, University of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain (J.B.).Address correspondence to C.W. (e-mail: [email protected]).Christoph Wald Mark W. RussoJulie K. HeimbachHero K. HussainElizabeth A. PomfretJordi BruixPublished Online:Feb 1 2013https://doi.org/10.1148/radiol.12121698MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In AbstractA new liver allocation policy featuring improved imaging criteria for hepatocellular carcinoma exceptions has been developed and approved by the Organ Procurement and Transplantation Network–United Network for Organ Sharing, in late 2011; radiologists in accredited transplantation centers in the United States are now challenged to implement the policy.References1 HRSA/OPTN. U.S. Department of Health and Human Services, Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov. Accessed November 23, 2012. Google Scholar2 HRSA/OPTN Data reports. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Updated July 7, 2012. Accessed July 7, 2012. Google Scholar3 Mazzaferro V, Regalia E, Doci R, et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693–699. Crossref, Medline, Google Scholar4 HRSA/OPTN. Policy 3.6 organ distribution: allocation of livers. http://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp. Published 2012. Accessed July 7, 2012. Google Scholar5 Committee on Organ Procurement and Transplantation Policy, Institute of Medicine. Procurement CoO, Policy T, Medicine Io. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academies Press, 1999. Google Scholar6 Kamath PS, Wiesner RH, Malinchoc M, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464–470. Crossref, Medline, Google Scholar7 Mayo Clinic. The MELD model, UNOS modification. Rochester, Minn: Mayo Clinic, 2012. http://www.mayoclinic.org/medl/mayomodel6.html. Accessed November 23, 2012. Google Scholar8 Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004;127(5 suppl 1):S261–S267. Crossref, Medline, Google Scholar9 Freeman RB, Mithoefer A, Ruthazer R, et al.. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 2006;12(10):1504–1511. Crossref, Medline, Google Scholar10 Feuerlein S, Gupta RT, Boll DT, Merkle EM. Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. Eur J Radiol 2012;81(9):2037–2041. Crossref, Medline, Google Scholar11 Motosugi U, Ichikawa T, Sano K, et al.. Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 2011;46(2):141–145. Crossref, Medline, Google Scholar12 Tamada T, Ito K, Sone T, et al.. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009;29(3):636–640. Crossref, Medline, Google Scholar13 Zech CJ, Vos B, Nordell A, et al.. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 2009;44(6):305–310. Crossref, Medline, Google Scholar14 Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol 2012;57(2):421–429. Crossref, Medline, Google Scholar15 Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008;247(2):311–330. Link, Google Scholar16 Khalili K, Kim TK, Jang HJ, Yazdi LK, Guindi M, Sherman M. Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none? Hepatology 2011;54(6):2048–2054. Crossref, Medline, Google Scholar17 Khalili K, Kim TK, Jang HJ, et al.. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization. J Hepatol 2011;54(4):723–728. Crossref, Medline, Google Scholar18 Forner A, Vilana R, Ayuso C, et al.. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47(1):97–104. Crossref, Medline, Google Scholar19 Kim SE, Lee HC, Shim JH, et al.. Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Liver Int 2011;31(10):1468–1476. Crossref, Medline, Google Scholar20 Sangiovanni A, Manini MA, Iavarone M, et al.. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010;59(5):638–644. Crossref, Medline, Google Scholar21 Ishigami K, Yoshimitsu K, Nishihara Y, et al.. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 2009;250(2):435–443. Link, Google Scholar22 Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 2010;32(2):360–366. Crossref, Medline, Google Scholar23 Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005;11(3):281–289. Crossref, Medline, Google Scholar24 Rimola J, Forner A, Tremosini S, et al.. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis: diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 2012;56(6):1317–1323. Crossref, Medline, Google Scholar25 Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Acta Radiol 2008;49(7):735–743. Crossref, Medline, Google Scholar26 Bolondi L, Gaiani S, Celli N, et al.. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42(1):27–34. Crossref, Medline, Google Scholar27 Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis. Eur Radiol 2011;21(6):1233–1242. Crossref, Medline, Google Scholar28 Vilana R, Forner A, Bianchi L, et al.. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010;51(6):2020–2029. Crossref, Medline, Google Scholar29 Yao FY, Kerlan RK, Hirose R, et al.. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48(3):819–827. Crossref, Medline, Google Scholar30 Kim TK, Lee KH, Jang HJ, et al.. Analysis of gadobenate dimeglumine–enhanced MR findings for characterizing small (1–2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 2011;259(3):730–738. Link, Google Scholar31 Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011;55(1):126–132. Crossref, Medline, Google ScholarArticle HistoryReceived August 24, 2012; revision requested September 21; final revision received October 5; final version accepted October 31.Published online: Feb 2013Published in print: Feb 2013 FiguresReferencesRelatedDetailsCited ByA Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER)Tze MinWah, MaciejPech, MaximilianThormann, XavierSerres, PeterLittler, BenjaminStenberg, JamesLenton, JonathanSmith, PhilippWiggermann, MathisPlanert, JoanVidal-Jove, GuidoTorzilli, LuigiSolbiati2023 | CardioVascular and Interventional Radiology, Vol. 46, No. 2Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADSSe JinChoi, Sang HyunChoi, Dong WookKim, MinhaKwag, Jae HoByun, Hyung JinWon, Yong MoonShin2023 | Journal of Hepatology, Vol. 78, No. 3Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlationKartik S.Jhaveri, AliBabaei Jandaghi, RajeshBhayana, Khaled Y.Elbanna, OsvaldoEspin-Garcia, Sandra E.Fischer, AnandGhanekar, GonzaloSapisochin2023 | Cancer Imaging, Vol. 23, No. 1Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRIEikoNishioka, KeitaroSofue, KojiMaruyama, EisukeUeshima, YoshikoUeno, MasakatsuTsurusaki, ShoheiKomatsu, TakumiFukumoto, TakamichiMurakami2023 | Scientific Reports, Vol. 13, No. 1Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosisChiaraRocha, Erin H.Doyle, Chip A.Bowman, M‐IsabelFiel, Ashley E.Stueck, NicolasGoossens, KianBichoupan, NealPatel, James F.Crismale, JasnitMakkar, SaraLewis, Ponni V.Perumalswami, Thomas D.Schiano, YujinHoshida, MyronSchwartz, Andrea D.Branch2023 | Cancer Medicine, Vol. 12, No. 9Liver Anatomy and Cross-Sectional Imaging Techniques: A Practical ApproachParul SamirGarde, Rahul BhagwanBhute2023 | Journal of Gastrointestinal and Abdominal Radiology, Vol. 06, No. 02Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trialChengxiangGuo, JunleiZhang, XinHuang, YiwenChen, JianpengSheng, XingHuang, JunhuiSun, WenboXiao, KeSun, ShunliangGao, RishengQue, YanShen, MinZhang, JianWu, XueliBai, TingboLiang2023 | Hepatology Communications, Vol. 7, No. 3Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinomaHaneyehShahbazian, MohammadMirza‐Aghazadeh‐Attari, AliBorhani, AlirezaMohseni, Seyedeh PanidMadani, GolnooshAnsari, Timothy M.Pawlik, Ihab R.Kamel2023 | Journal of Surgical OncologyMultimodality Imaging after Liver Transplant: Top 10 Important ComplicationsClaire E. Brookmeyer, Shweta Bhatt, Elliot K. Fishman, Sheila Sheth, 4 March 2022 | RadioGraphics, Vol. 42, No. 3Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classificationJi YoungChoi, JiyeonHa, Sang HyunChoi, Hyo JeongKang, So YeonKim, Kyoung WonKim2022 | Abdominal Radiology, Vol. 47, No. 3The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center ExperiencePanitaMettikanont, AnitaKalluri, ThereseBittermann, NeilPhillips, Bao-LiLoza, MarkRosen, EvanSiegelman, EmmaFurth, PeterAbt, KimOlthoff, AbrahamShaked, MaaroufHoteit, K. RajenderReddy2022 | Journal of Clinical and Experimental Hepatology, Vol. 12, No. 4Changing opportunities for liver transplant for patients with hepatocellular carcinomaAlexZendel, RandallWatkins, Andrew M.Moon, David A.Gerber, A. SidneyBarritt, Chirag S.Desai2022 | Clinical Transplantation, Vol. 36, No. 5Hepatobiliary phase images of gadoxetic acid-enhanced MRI may improve accuracy of predicting the size of hepatocellular carcinoma at pathologySan-YuanDong, Yu-TaoYang, Wen-TaoWang, ShuoZhu, WeiSun, Meng-SuZeng, Sheng-XiangRao2022 | Acta Radiologica, Vol. 63, No. 6Liver resection of hepatocellular carcinoma in HIV-HCV co-infected patients: a retrospective case seriesFrancescoCammarata, LauraBenuzzi, MicheleCrespi, AlbertTroci, LucaPennacchi, MonicaSchiavini, DiegoFoschi2022 | Egyptian Liver Journal, Vol. 12, No. 1The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI MalignanciesShashankSrinivasan, ArchyaDasgupta, AbhishekChatterjee, AkshayBaheti, ReenaEngineer, TejpalGupta, VedangMurthy2022 | JCO Global Oncology, No. 8Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination toolYapeiZhang, CatherineMezzacappa, LinShen, AmandaIvatorov, AlexandraPetukhova-Greenstein, RajniMehta, MariaCiarleglio, YanhongDeng, WoodyLevin, SteveSteinhardt, DonnaConnery, MichaelPineau, IfeyinwaOnyiuke, CarolineTaylor, Michal G.Rose, Tamar H.Taddei, JessicaKeim-Malpass2022 | PLOS Digital Health, Vol. 1, No. 8Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver TransplantationGuilherme MouraCunha, MojganHosseini, AlessandroFurlan, Kathryn J.Fowler2022 | American Journal of Roentgenology, Vol. 218, No. 1LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS CriteriaYangHuang, Meng-FeiXian, Wen-XuanXie, Kang-MingPan, DanZeng, HuiHuang, Ming-DeLi, Xiao-YanXie, MingKuang, Ming-DeLu, Li-DaChen, WeiWang2022 | American Journal of Roentgenology, Vol. 219, No. 1Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference StandardMalte N.Bongers, SvenWalter, JanFritz, GeorgBier, MariusHorger, ChristophArtzner2022 | American Journal of Roentgenology, Vol. 218, No. 6Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular CarcinomaJae SeokBae, Dong HoLee, Sang MinLee, Kyung-SukSuh, Kwang-WoongLee, Nam-JoonYi, Kyoung BunLee, HaeryoungKim, Joon KooHan2022 | American Journal of Roentgenology, Vol. 219, No. 1Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma DetectionLinglingLi, WeiZheng, JianweiWang, JingHan, ZhixingGuo, YixinHu, XiaoxianLi, JianhuaZhou2022 | American Journal of Roentgenology, Vol. 219, No. 3Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance UltrasoundJustin R.Tse, LuyaoShen, Kristen N.Bird, LukeYoon, AyaKamaya2022 | American Journal of Roentgenology, Vol. 219, No. 5From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative SurgeryLeonardoCentonze, RiccardoDe Carlis, IvanVella, LucaCarbonaro, NiccolòIncarbone, LiviaPalmieri, CristianoSgrazzutti, AlbertoFicarelli, Maria GraziaValsecchi, UmbertoDello Iacono, AndreaLauterio, DavideBernasconi, AngeloVanzulli, LucianoDe Carlis2022 | Diagnostics, Vol. 12, No. 1LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular CarcinomaMishalMendiratta-Lala, AnumAslam, Katherine E.Maturen, MariaWesterhoff, ChrisMaurino, Neehar D.Parikh, YilunSun, Christopher J.Sonnenday, Erica B.Stein, Kimberly L.Shampain, Ravi K.Kaza, KyleCuneo, WilliamMasch, Richard Kinh GianDo, Theodore S.Lawrence, DawnOwen2022 | International Journal of Radiation Oncology*Biology*Physics, Vol. 112, No. 3Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS CategorizationNikita Consul, Claude B. Sirlin, Victoria Chernyak, David T. Fetzer, William R. Masch, Sandeep S. Arora, Richard K. G. Do, Robert M. Marks, Kathryn J. Fowler, Amir A. Borhani, Khaled M. Elsayes, 24 September 2021 | RadioGraphics, Vol. 41, No. 6How to Use LI-RADS to Report Liver CT and MRI ObservationsGuilherme M. Cunha, Kathryn J. Fowler, Alexandra Roudenko, Bachir Taouli, Alice W. Fung, Khaled M. Elsayes, Robert M. Marks, Irene Cruite, Natally Horvat, Victoria Chernyak, Claude B. Sirlin, An Tang, 23 July 2021 | RadioGraphics, Vol. 41, No. 5LI‐RADS: Review and updatesMohabElmohr, Khaled M.Elsayes, VictoriaChernyak2021 | Clinical Liver Disease, Vol. 17, No. 3Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI : Pitfalls and Potential TipsJae HyunKim, Jeong HeeYoon, IjinJoo, Jeong MinLee2021 | Journal of Magnetic Resonance Imaging, Vol. 53, No. 3Diagnostic Performance of Liver Imaging Reporting and Data System Version 2017 Versus Version 2018 for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Comparative StudiesYeun‐YoonKim, SunyoungLee, JaeseungShin, Won JeongSon, HyejungShin, Ji EunLee, Jeong AhHwang, Yong EunChung, Jin‐YoungChoi, Mi‐SukPark2021 | Journal of Magnetic Resonance Imaging, Vol. 54, No. 6LI-RADS and transplantation: challenges and controversiesGuilherme M.Cunha, Dorathy E.Tamayo-Murillo, Kathryn J.Fowler2021 | Abdominal Radiology, Vol. 46, No. 1Contrast media injection protocol for portovenous phase abdominal CT: does a fixed injection duration improve hepatic enhancement over a fixed injection rate?Andreu F.Costa, KrisPeet2021 | Abdominal Radiology, Vol. 46, No. 6Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liverPaula M.Oestmann, Clinton J.Wang, Lynn J.Savic, Charlie A.Hamm, SophieStark, IsabelSchobert, BernhardGebauer, ToddSchlachter, MingDeLin, Jeffrey C.Weinreb, RameshBatra, DavidMulligan, XuchenZhang, James S.Duncan, JuliusChapiro2021 | European Radiology, Vol. 31, No. 7Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experienceWeiLi, LvLi, Bo-WenZhuang, Si-MinRuan, Hang-TongHu, YangHuang, Man-xiaLin, Xiao-YanXie, MingKuang, Ming-DeLu, Li-DaChen, WeiWang2021 | European Radiology, Vol. 31, No. 9Advanced CT techniques for assessing hepatocellular carcinomaYukoNakamura, ToruHigaki, YukikoHonda, FuminariTatsugami, ChihiroTani, WataruFukumoto, KeigoNarita, ShotaKondo, MotonoriAkagi, KazuoAwai2021 | La radiologia medica, Vol. 126, No. 7Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): An Overview with Technical and Practical ApplicationsHailey H.Choi, Shuchi K.Rodgers, David T.Fetzer, Ashish P.Wasnik, John D.Millet, Tara A.Morgan, AdrianDawkins, HelenaGabriel, AyaKamaya2021 | Academic Radiology, Vol. 28, No. 10Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysisYingyingLiang, FanXu, YuanGuo, LishaLai, XinqingJiang, XinhuaWei, HongzhenWu, JinWang2021 | European Journal of Radiology, Vol. 134Single-cell fucosylation breakdown: Switching fucose to europiumZhenLiu, YongLiang, YangZhou, FuchunGe, XiaowenYan, LiminYang, QiuquanWang2021 | iScience, Vol. 24, No. 5Access to Liver Transplantation for Hepatocellular Carcinoma: Does Candidate Age Matter?OlaAhmed, NeetaVachharajani, Su-HsinChang, YikyungPark, Adeel S.Khan, William C.Chapman, Majella B.Doyle2021 | Journal of the American College of Surgeons, Vol. 233, No. 1Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation StudyBeauToskich, Lucas L.Vidal, Matthew T.Olson, Jason T.Lewis, Jordan D.LeGout, David M.Sella, S. AliMontazeri, ZlatkoDevcic, Andrew R.Lewis, Greg T.Frey, Charles A.Ritchie, RicardoPaz-Fumagalli, Kristopher P.Croome, Tushar C.Patel2021 | Journal of Vascular and Interventional Radiology, Vol. 32, No. 4The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular CarcinomaFrancis Y.Yao, NicholasFidelman, NeilMehta2021 | Seminars in Liver Disease, Vol. 41, No. 02Radiation SegmentectomyKristinaPrachanronarong, EdwardKim2021 | Seminars in Interventional Radiology, Vol. 38, No. 04A retrospective single‐centre analysis of the oncological impact of LI‐RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule mattersLeonardoCentonze, StefanoDi Sandro, AndreaLauterio, RiccardoDe Carlis, CristianoSgrazzutti, CristinaCiulli, IvanVella, IlariaVicentin, NiccolòIncarbone, VincenzoBagnardi, AngeloVanzulli, LucianoDe Carlis2021 | Transplant International, Vol. 34, No. 9Effects of Combined Epidural Anesthesia and General Anesthesia on Cognitive Function and Stress Responses of Elderly Patients Undergoing Liver Cancer SurgeryZhixiuMeng, CaoGao, XinLi, JiangShen, TaoHong, XiaofengHe, LeijunZhu, AlamgeerYuchi2021 | Journal of Oncology, Vol. 2021Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular CarcinomaGuilhermeMoura Cunha, VictoriaChernyak, Kathryn JFowler, Claude BSirlin2021 | Journal of Hepatocellular Carcinoma, Vol. Volume 8Assessing Global Organ Donation Policies: Opt-In vs Opt-OutHarriet RosanneEtheredge2021 | Risk Management and Healthcare Policy, Vol. Volume 14Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and CholangiocarcinomaBadawy A.Abdulaziz, WaleedEl Agawy, Mohamed El-TantawyIbrahim, Medhat A.Khalil, Walid A.Abdel Halim2021 | The Open Biomarkers Journal, Vol. 11, No. 1Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma ScreeningJeong WooKim, Chang HeeLee2021 | Journal of the Korean Society of Radiology, Vol. 82, No. 2Intraindividual Comparison of Hepatocellular Carcinoma Washout between MRIs with Hepatobiliary and Extracellular Contrast AgentsYeun-YoonKim, Young KonKim, Ji HyeMin, Dong IkCha, Jong ManKim, Gyu-SeongChoi, SoohyunAhn2021 | Korean Journal of Radiology, Vol. 22, No. 5Facile Assembly of Thermosensitive Liposomes for Active Targeting Imaging and Synergetic Chemo-/Magnetic Hyperthermia TherapyYanliAn, RuiYang, XihuiWang, YongHan, GangJia, ChunmeiHu, ZhiyuanZhang, DongfangLiu, QiushaTang2021 | Frontiers in Bioengineering and Biotechnology, Vol. 9Locoregional Treatments for Bridging and Downstaging HCC to Liver TransplantationLauraCrocetti, ElenaBozzi, PaolaScalise, IreneBargellini, GiuliaLorenzoni, DavideGhinolfi, DanielaCampani, EmanueleBalzano, PaoloDe Simone, RobertoCioni2021 | Cancers, Vol. 13, No. 21Measuring HCC Tumor Size in MRI—The Sequence Matters!MarcoArmbruster, MarkusGuba, JoachimAndrassy, MarkusRentsch, VincentSchwarze, JohannesRübenthaler, ThomasKnösel, JensRicke, HaraldKramer2021 | Diagnostics, Vol. 11, No. 11Chronic Liver Disease and Liver CancerColinO’Rourke, ShivaJayaraman, Robert H.El-Maraghi, Amit G.Singal, Ania Z.Kielar2021 | Magnetic Resonance Imaging Clinics of North America, Vol. 29, No. 3HepatocarcinogenesisAliceFung, Krishna P.Shanbhogue, Myles T.Taffel, Brian T.Brinkerhoff, Neil D.Theise2021 | Magnetic Resonance Imaging Clinics of North America, Vol. 29, No. 3Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver DiseaseRobertoCannella, Guilherme MouraCunha, RobertaCatania, KalinaChupetlovska, Amir A.Borhani, Kathryn J.Fowler, AlessandroFurlan2021 | Magnetic Resonance Imaging Clinics of North America, Vol. 29, No. 3Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) ConsortiumNeilMehta, CatherineFrenette, ParissaTabrizian, MaaroufHoteit, JenniferGuy, NeeharParikh, T. TaraGhaziani, RenuDhanasekaran, Jennifer L.Dodge, BrahmaNatarajan, Matthew L.Holzner, LeanaFrankul, WesleyChan, AustinFobar, SanderFlorman, Francis Y.Yao2021 | Gastroenterology, Vol. 161, No. 5Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver TransplantationPaul J.Thuluvath, ChauTo, WaseemAmjad2021 | American Journal of Gastroenterology, Vol. 116, No. 1Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B InfectionWei Zheng, Qing Li, Xue-bin Zou, Jian-wei Wang, Feng Han, Fei Li, Li-shu HuangAn-hua Li, Jian-hua Zhou, 26 November 2019 | Radiology, Vol. 294, No. 2MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive ReviewMishal Mendiratta-Lala, William R. Masch, Kimberly Shampain, Andrew Zhang, Alexandria S. Jo, Sarah Moorman, Anum Aslam, Katherine E. Maturen, Matthew S. Davenport, 31 January 2020 | Radiology: Imaging Cancer, Vol. 2, No. 1Abbreviated‐protocol screening MRI vs. complete‐protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI‐RADS v2018GauravKhatri, IvanPedrosa, LakshmiAnanthakrishnan, Alberto DiazLeon, David T.Fetzer, JohnLeyendecker, Amit G.Singal, YinXi, AdamYopp, TakeshiYokoo2020 | Journal of Magnetic Resonance Imaging, Vol. 51, No. 2Interreader Agreement of Liver Imaging Reporting and Data System on MRI: A Systematic Review and Meta‐AnalysisJi HunKang, Sang HyunChoi, Ji SungLee, Seong HoPark, Kyung WonKim, So YeonKim, Seung SooLee, Jae HoByun2020 | Journal of Magnetic Resonance Imaging, Vol. 52, No. 3Evaluation and Management of Liver MassesEric C.Ehman, Michael S.Torbenson, Christopher L.Hallemeier, Julie K.Heimbach, Lewis R.Roberts2020Prevalence and clinical significance of discordant LI-RADS® observations on multiphase contrast-enhanced MRI in patients with cirrhosisTakeshiYokoo, Amit G.Singal, AlbertoDiaz de Leon, LakshmiAnanthakrishnan, David T.Fetzer, IvanPedrosa, GauravKhatri2020 | Abdominal Radiology, Vol. 45, No. 1Examining LI-RADS recommendations: should observation size only be measured on non-arterial phases?Guilherme M.Cunha, HeejinKwon, TanyaWolfson, Anthony C.Gamst, Yong EunChung, Min-JeongKim, Sang WonKim, Claude B.Sirlin, Kathryn J.Fowler2020 | Abdominal Radiology, Vol. 45, No. 10Natural history of hepatocellular carcinoma after stereotactic body radiation therapyMishalMendiratta-Lala, WilliamMasch, DawnOwen, AnumAslam, ChrisMaurino, TheresaDevasia, Matthew J.Schipper, Neehar D.Parikh, KyleCuneo, Theodore S.Lawrence, Matthew S.Davenport2020 | Abdominal Radiology, Vol. 45, No. 11Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acidSaharSemaan, NaikVietti Violi, SaraLewis, ManjilChatterji, ChristopherSong, CeciliaBesa, James S.Babb, M. IsabelFiel, MyronSchwartz, SwanThung, Claude B.Sirlin, BachirTaouli2020 | European Radiology, Vol. 30, No. 2Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid–enhanced MRI in transplantation candidatesSun KyungJeon, Jeong MinLee, IjinJoo, JeonginYoo, Jin-youngPark2020 | European Radiology, Vol. 30, No. 9Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screeningNaikVietti Violi, SaraLewis, JosephLiao, MiriamHulkower, GabrielaHernandez-Meza, KatherineSmith, James S.Babb, XingChin, JosephSong, DanielaSaid, ShingoKihira, Claude B.Sirlin, Scott B.Reeder, Mustafa R.Bashir, Kathryn J.Fowler, Bart S.Ferket, KeithSigel, BachirTaouli2020 | European Radiology, Vol. 30, No. 11Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or UnderuseVarunSaxena, NeilMehta2020 | Current Hepatology Reports, Vol. 19, No. 4Imaging Diagnosis of Hepatocellular CarcinomaGuilherme MouraCunha, Kathryn J.Fowler, FaridAbushamat, Claude B.Sirlin, YukoKono2020 | Clinics in Liver Disease, Vol. 24, No. 4Accuracy of liver ablation zone prediction in a single 2450 MHz 100 Watt generator model microwave ablation system: An in human studyS.Young, M.Rivard, R.Kimyon, T.Sanghvi2020 | Diagnostic and Interventional Imaging, Vol. 101, No. 4WITHDRAWN: Diagnostic Performance of LI-RADS for MRI and CT Detection of HCC: A Systematic Review and Diagnostic Meta-analysisYingyingLiang, FanXu, YuanGuo, LishaLai, XinqingJiang, XinhuaWei, HongzhenWu, Kathryn J.Fowler, Claude B.Sirlin, JinWang2020 | European Journal of RadiologyAdvances in the early diagnosis of hepatocellular carcinomaWeiyiWang, ChaoWei2020 | Genes & Diseases, Vol. 7, No. 3Liver Imaging Reporting and Data System Version 2018Ahmed Abdel KhalekAbdel Razek, Lamiaa GalalEl-Serougy, Gehad AhmadSaleh, WalaaShabana, RihameAbd El-wahab2020 | Journal of Computer Assisted Tomography, Vol. 44, No. 2Proceedings of the 4th International Conference on Medical and Health InformaticsMoathAl-Makhamreh, MuradAbusamra, MohammadHjouj2020Fontan-Associated Liver DiseaseJulietEmamaullee, Ali N.Zaidi, ThomasSchiano, JeffreyKahn, Pamela L.Valentino, Ryan E.Hofer, TimucinTaner, Joyce W.Wald, Kim M.Olthoff, Jo
Referência(s)